Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- Haymaker Acquisition Corp. II (the “Company”) announced today that, commencing July 23, 2019, holders of the 40,000,000 units sold in the Company’s...
-
CALGARY, Alberta, July 19, 2019 (GLOBE NEWSWIRE) -- West High Yield (W.H.Y.) Resources Ltd. ("West High Yield" or the "Company") (TSXV: WHY) announces that it has completed the second and final...
-
WESTLAKE VILLAGE, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced the repayment of outstanding debt by an aggregate amount of approximately $4.0 million...
-
Boussard & Gavaudan Holding Limited a closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Proposed conversion of...
-
Boussard & Gavaudan Holding Limited a closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Proposed conversion of...
-
Olaregen Silver SponsorshipDr. Lois Chandler, PhD Presents Excellagen Research as Keynote Speaker at Wound Care SymposiumRapid Acceleration of Healing with Wound Conforming, Native Structural Matrix -...
-
TEGUCIGALPA, HONDURAS, July 12, 2019 (GLOBE NEWSWIRE) -- Dinant has retained prestigious international certifications recognizing significant improvements across the company’s operations. All...
-
TORONTO, July 08, 2019 (GLOBE NEWSWIRE) -- Discovery Metals Corp. (TSX-V: DSV) (“Discovery” or the “Company”) announces it has received approval from the TSX Venture Exchange (the “TSXV”) to extend...
-
MELBOURNE, Austrália e PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- A Telix Pharmaceuticals Limited (ASX.TLX) ( “Telix”, a “Empresa”), uma empresa biofarmacêutica de fase clínica...
-
MELBOURNE, Australia y PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, la “Compañía”), una compañía biofarmacéutica en fase-clínica,...